The level of APLP1β27 showed a trend towards decreased levels in a dose-dependent manner in response to treatment but it did not reach statistical significance for either of the doses (Fig. 4f ).
← all excerpts
APLP1 as a cerebrospinal fluid biomarker for γ-secretase modulator treatment.
1
—
—